Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Patient Engagement for the Life Sciences

    September 12, 2018 | Patient-centric, Patient-centricity, life sciences, patient engagement 

    Patient Engagement for the Life Sciences, written by Guy Yeoman and Mitchell Silva with editorial and design support from Cuttsy+Cuttsy, explains the ‘why’ and the ‘how’ of patient engagement. It presents the compelling argument for why life science companies need to embrace and partner with patients and outlining an operating framework for doing it effectively.

    Visit www.medipace.com/book to download your copy.

    We’re really proud to have been working with Guy Yeoman and Mitch Silva on their new book, Patient Engagement for the Life Sciences. To celebrate the book launch, we’ve been talking to Guy about why patient engagement is so important to pharma. I’m a firm believer and I’m passionate about effective patient engagement. I think it delivers value for the industry, but also for patients and society at large. My background is in the pharmaceutical business. I’ve been working for the last two decades in the industry, and over the last three years I’ve built a patient-engaging capability for a large pharma organisation. So I come with that corporate, strategic background. The co-author of the book, Mitchell Silva, is a patient. He’s a patient expert himself, he’s a EUPATI scholar, and he’s built a virtual patient network for patients with cancer. So between us we bring both perspectives. We demonstrate clearly in the book why the industry needs to change, but also how it needs to change and what operating framework could be put in place that enables effective patient engagement, delivering value for both the industry as well as the patients and allied stakeholders.

    This content was provided by Cuttsy + Cuttsy

    Company Details

    Cuttsy and Cuttsy Logo

    Cuttsy + Cuttsy

    Email
    Website

     Latest Content from  Cuttsy + Cuttsy 

    Cuttsy+Cuttsy achieves Platinum accreditation from Investors in People

    Cuttsy+Cuttsy is proud to have achieved a Platinum accreditation from Investors in People, placing them among the top 2% of organisations assessed globally.

    Cuttsy+Cuttsy awarded Gold EcoVadis sustainability rating

    Cuttsy+Cuttsy proudly announces their Gold Medal achievement from EcoVadis for 2024, placing them among the top 5% of companies assessed and within the 97th percentile, a testament to their unwavering...

    Age is not just a number when it comes to clinical trials

    In this blog we look at the critical underrepresentation of older adults in clinical trials, emphasising the need for inclusive trial designs and targeted strategies to ensure safe and effective...

    How to boost clinical trial access and make patients health-empowered

    Clinical research is becoming more patient-centric, but there's still more that needs to be done to make clinical trials available to everyone. This could include wider participation.

    Closing the loop: Why clinical trial results matter to participants

    Discover why sharing clinical trial results with participants is crucial for respect, informed health decisions, and fostering strong researcher-participant partnerships.

    Unveiling the truth: A journey into women’s representation in clinical trials

    We explore the historical exclusion of women from clinical trials, its consequences on medical research and treatment efficacy and the ongoing efforts to ensure their representation.

    Clarity in clinical trials

    Discover how transparent, empathetic communication and health literacy principles can empower patients and enhance engagement in clinical trials, transforming participants into active partners in their healthcare journey.

    Caring for patients’ mental health in clinical trials

    We look at why ensuring continuous mental health support for patients in clinical trials is essential to enhance their overall well-being and trial engagement.

    Driving equitable healthcare: The role of DE&I in clinical trials

    Diversity, equity and inclusion (DE&I) is becoming a bigger topic of conversation and meaningful action within clinical trials. And for good reason, too. Find out why we embrace this and...

    Empowering patients through more accessible clinical trial information

    Senior Medical Writer, Scott Palmer explores the challenges and solutions in enhancing patient engagement in clinical trials, from the pivotal role of healthcare professionals, to the importance of user-friendly trial...